Medulloblastoma Clinical Trials in St Louis, Missouri
7 recruitingSt Louis, Missouri
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma
MedulloblastomaEpendymomaDiffuse Midline Glioma+1 more
Washington University School of Medicine68 enrolled3 locationsNCT06639607
Recruiting
Phase 1
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
NeoplasmsNeoplasms by SiteBrain Diseases+30 more
M.D. Anderson Cancer Center24 enrolled3 locationsNCT03911388
Recruiting
Phase 2
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade GliomaDiffuse Intrinsic Pontine GliomaRecurrent Medulloblastoma
Nationwide Children's Hospital120 enrolled13 locationsNCT05096481
Recruiting
Phase 3
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Children's Oncology Group225 enrolled105 locationsNCT05382338
Recruiting
Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
Medulloblastoma
Giselle Sholler118 enrolled24 locationsNCT04696029
Recruiting
Not Applicable
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
MedulloblastomaEpendymomaEpendymoma of Brain+3 more
University of California, San Francisco74 enrolled8 locationsNCT05057702
Recruiting
Phase 2
Digoxin Medulloblastoma Study
MedulloblastomaMedulloblastoma, Non-WNT/Non-SHH
H. Lee Moffitt Cancer Center and Research Institute23 enrolled15 locationsNCT06701812